Schroder Investment Management Group’s BeOne Medicines Ltd ONC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14M	Buy	49,344 +9,511	+24%	+$3.08M	0.01%	594
2025 Q4	$12.1M	Buy	39,833 +27,783	+231%	+$9.09M	0.01%	607
2025 Q3	$4.01M	Sell	12,050 -18,019	-60%	-$5.47M	﹤0.01%	808
2025 Q2	$7.28M	Buy	30,069 +11,462	+62%	+$2.81M	0.01%	692
2025 Q1	$4.98M	Sell	18,607 -67,722	-78%	-$15.8M	0.01%	758
2024 Q4	$15.9M	Buy	86,329 +54,030	+167%	+$11M	0.02%	567
2024 Q3	$7.05M	Sell	32,299 -51,989	-62%	-$9.35M	0.01%	731
2024 Q2	$12M	Buy	84,288 +10,427	+14%	+$1.61M	0.01%	605
2024 Q1	$11.6M	Buy	73,861 +61,161	+482%	+$9.85M	0.01%	623
2023 Q4	$2.29M	Buy	+12,700	New	+$2.3M	﹤0.01%	888
2022 Q1	–	Sell	-273	Closed	-$6K	–	1617
2021 Q4	$6K	Sell	273 -276	-50%	-$93.2K	﹤0.01%	1396
2021 Q3	$15K	Buy	549 +507	+1,207%	+$166K	﹤0.01%	1440
2021 Q2	$14K	Sell	42 -2,997	-99%	-$993K	﹤0.01%	1467
2021 Q1	$1.06M	Buy	+3,039	New	+$1.01M	﹤0.01%	1148
2020 Q4	–	Sell	-145	Closed	-$41K	–	1513
2020 Q3	$41K	Buy	+145	New	+$34.1K	﹤0.01%	1273
2020 Q2	–	Sell	-83	Closed	-$12K	–	1354
2020 Q1	$12K	Buy	+83	New	+$13K	﹤0.01%	1277
2018 Q2	–	Sell	-2,800	Closed	-$470K	–	1332
2018 Q1	$470K	Buy	+2,800	New	+$379K	﹤0.01%	1064